D.Western Therapeutics Institute, Inc. (JP:4576) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
D.Western Therapeutics Institute, Inc. reports a challenging first half of 2024, with net sales slightly up by 19.1% to 223 million yen, yet facing significant losses, including a net loss of 520 million yen attributable to owners. The company’s total assets also decreased to 2,065 million yen compared to the end of the previous year, and no dividends were paid or forecasted for 2024 amidst the downturn. The full-year forecast anticipates a continued decline in performance, with a projected net loss of 1,510 million yen and no improvement in operating or ordinary profits.
For further insights into JP:4576 stock, check out TipRanks’ Stock Analysis page.